Patients with autism exhibit altered cognitive function that is revealed in EEG recordings as an imbalance of excitation to inhibition in the cerebral cortex. Imbalanced excitation / inhibition could be the product of multiple alterations of brain structure and function, such as an altered ratio of pyramidal neurons to interneurons in the autistic cerebral cortex. Imbalanced excitation / inhibition could also be produced by an alteration in the number of non-neuronal cell types (such as oligodendrocytes or astrocytes) that participate in neurotransmission; and / or by altered morphology or density of neuronal dendrites and dendritic spines in the cerebral cortex. Existing data on the relative number of specific cell types in the cerebral cortex of human autistic brains is at this point insufficient, as is data on the morphology of neurons in the human autistic cerebral cortex. The number of published studies is scarce, the number of cases included in the published studies is small, and the cases used for analysis is heterogeneous. A full understanding of the cellular basis of autism in human brain is essential for establishing the basic underlying mechanisms that, in turn, will result in therapeutic interventions. This project will analyze the temporal lobe of 21 autistic postmortem human brains (diagnosed as autistic, not as other autism spectrum disorders) and the temporal lobe of 18 control postmortem human brains, and investigate: 1) Density of total neurons, pyramidal neurons, and interneuronal subtypes in the autistic versus control temporal cortex using unbiased stereological methods for cell quantification. 2) Density of total glial cells, astrocytes, and oligodendrocytes in the autistic versus control temporal cortex using unbiased stereological methods. Cellular classification will be based on cellular morphology in Nissl stained sections, and on cellular marker expression in immunohistochemical experiments. 3) Dendrite length, dendritic branching, and spine density in the temporal lobe of autistic and control brains. We will stain neurons using the Golgi method, Neurolucida and the Scholl method to determine total dendritic length, total number of dendritic branches and spine density in pyramidal neurons and interneurons. We will classify our cases based on the subject's clinical history, including age, the presence of seizures or mental retardation, and the levels of social, communicative, and repetitive behaviors. We will statistically compare densities in the autistic versus control temporal cortex within clinical categories. A full understanding of the cellular basis of autism in the human brain is essential for establishing underlying mechanisms that in turn could yield new therapeutic interventions. The data obtained from this project will also serve as the basis for future studies focusing on the neuropathology and the imbalance excitation / inhibition of the autistic brain.
Autism is a neurodevelopmental disorder defined by a pattern of qualitative abnormalities in reciprocal social interaction, communication, and repetitive interest and behavior. It is estimated that 1 in 110 children in the United States have autism spectrum disorders. The proposed project investigates the contribution of the density and morphology of distinct cortical cell types in the temporal lobe, to the pathogenesis of autism. A full understanding of the cellular basis of autism in the human brain is essential for establishing underlying mechanisms that in turn could yield new therapeutic interventions.
| Martínez-Cerdeño, Verónica; García-Moreno, Fernando; Tosches, Maria Antonietta et al. (2018) Update on forebrain evolution: From neurogenesis to thermogenesis. Semin Cell Dev Biol 76:15-22 |
| Liu, Fang; Horton-Sparks, Kayla; Hull, Vanessa et al. (2018) The valproic acid rat model of autism presents with gut bacterial dysbiosis similar to that in human autism. Mol Autism 9:61 |
| Martínez Cerdeño, Verónica; Hong, Tiffany; Amina, Sarwat et al. (2018) Microglial cell activation and senescence are characteristic of the pathology FXTAS. Mov Disord : |
| Martínez-Cerdeño, Verónica; Lechpammer, Mirna; Hagerman, Paul J et al. (2017) Two FMR1 premutation cases without nuclear inclusions. Mov Disord 32:1328-1329 |
| Martínez-Cerdeño, Verónica (2017) Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models. Dev Neurobiol 77:393-404 |
| Martínez-Cerdeño, Verónica; Lechpammer, Mirna; Noctor, Stephen et al. (2017) FMR1 premutation with Prader-Willi phenotype and fragile X-associated tremor/ataxia syndrome. Clin Case Rep 5:625-629 |
| Ariza, Jeanelle; Rogers, Hailee; Hartvigsen, Anna et al. (2017) Iron accumulation and dysregulation in the putamen in fragile X-associated tremor/ataxia syndrome. Mov Disord 32:585-591 |
| Lechpammer, Mirna; Martínez Cerde?o, Verónica; Hunsaker, Michael Ryan et al. (2017) Concomitant occurrence of FXTAS and clinically defined sporadic inclusion body myositis: report of two cases. Croat Med J 58:310-315 |
| Hashemi, Ezzat; Ariza, Jeanelle; Rogers, Haille et al. (2017) The Number of Parvalbumin-Expressing Interneurons Is Decreased in the Prefrontal Cortex in Autism. Cereb Cortex 27:1931-1943 |
| Rogers, Hailee; Ariza, Jeanelle; Monterrubio, Angela et al. (2016) Cerebellar Mild Iron Accumulation in a Subset of FMR1 Premutation Carriers with FXTAS. Cerebellum 15:641-4 |
Showing the most recent 10 out of 27 publications
